Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24

August saw stocks bouncing back despite a rough start. Key focus includes the Federal Reserve's upcoming decisions and their effects on the market, especially for major tech players like Apple. Intel is navigating its market struggles and strategizing for recovery amidst innovation challenges. There's exciting news with Emergent Bio's FDA approval for a smallpox vaccine, potentially reshaping its future. Additionally, insights into retail performances, particularly Ulta Beauty, highlight the ever-changing landscape of the financial market.